Mark Hilliard is a Principal Scientist in MSAT at Pfizer, where they provide mass spectrometry expertise to a multidisciplinary analytical team focused on the characterization and analysis of therapeutic biologics. They previously served as a Characterisation Scientist at Pfizer, contributing to glycoprotein and vaccine analysis, and have held roles in various organizations, including Senior Research Scientist at NIBRT and QC Technician at Trinity Biotech PLC. Mark completed a Ph.D. at RCSI and holds a Bachelor of Science Honours from the Institute of Technology, Tallaght.
This person is not in the org chart
This person is not in any teams
This person is not in any offices